CHICAGO: Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence-driven precision medicine, announced Friday it has acquired Paige, a digital pathology company known for pioneering FDA-cleared AI applications in cancer detection. The $81.25 million deal, primarily paid in Tempus…
SYDNEY, AUSTRALIA: Sonic Healthcare (ASX: SHL) has signed binding agreements to acquire Pathology Watch, a medical technology business headquartered in Salt Lake City, Utah, USA, which has developed and commercialised an integrated, end-to-end digital pathology platform for skin pathology (dermatopathology)….
STOCKHOLM, SWEDEN: ContextVision AB, a medical technology software company, is conducting a review of the company’s structure, and has initiated work assessing a spin-off of the Digital Pathology unit with a goal of listing the new entity on the Euronext…